智通财经APP讯，万泰生物(603392.SH)发布公告，近日，公司自主研发的结核感染T细胞检测试剂盒(体外释放酶联免疫法)(以下简称“TB-IGRA检测试剂盒”)被纳入联合国项目事务署(UNOPS)管理的StopTB Partnership采购清单。
公告称，UNOPS作为联合国系统内重要的采购机构，其采购清单的纳入意味着公司的TB-IGRA检测试剂盒获得了国际权威认可，可直接参与联合国及全球多边机构的集中采购项目，覆盖更多发展中国家和地区，将对公司开拓国际市场带来积极影响，有利于进一步提升公司产品的国际竞争力。结核病是全球公共卫生问题，UNOPS等机构在医疗物资采购中尤其关注结核病筛查和防治产品，公司TB-IGRA检测试剂盒通过UNOPS进入此类采购链，有助于满足全球中低收入国家对结核病检测的需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.